Pharmacogenetics: Separating Science from Marketing
Psychopharmacology and Psychiatry Updates
00:00
Atomoxetine and CYP2D6 poor metabolizers
Chris Aiken explains atomoxetine's tenfold higher levels in CYP2D6 poor metabolizers causing severe sedation in a subset of patients.
Play episode from 04:55
Transcript
